Atomi Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.84M Buy
242,706
+159,955
+193% +$4.18M 0.15% 120
2026
Q1
$2.32M Buy
82,751
+12,196
+17% +$325K 0.07% 219
2025
Q4
$1.76M Buy
70,555
+18,483
+35% +$466K 0.05% 260
2025
Q3
$1.33M Buy
52,072
+14,132
+37% +$349K 0.04% 290
2025
Q2
$920K Sell
37,940
-6,288
-14% -$147K 0.03% 365
2025
Q1
$1.12M Buy
44,228
+10,941
+33% +$286K 0.05% 277
2024
Q4
$883K Sell
33,287
-9,146
-22% -$248K 0.04% 300
2024
Q3
$1.23M Buy
42,433
+4,583
+12% +$134K 0.08% 202
2024
Q2
$1.06M Buy
37,850
+428
+1% +$11.8K 0.08% 199
2024
Q1
$1.04M Buy
37,422
+19,024
+103% +$528K 0.1% 178
2023
Q4
$530K Buy
18,398
+4,444
+32% +$134K 0.07% 252
2023
Q3
$463K Buy
13,954
+708
+5% +$25K 0.15% 167
2023
Q2
$486K Buy
13,246
+488
+4% +$19K 0.22% 131
2023
Q1
$521K Buy
+12,758
New +$551K 0.29% 95

Other funds holding PFE

Atomi Financial Group's PFE Position: Q2 2026 in Review

Atomi Financial Group increased its Pfizer (PFE) stake by 193% in Q2 2026, buying an estimated $4.18M and bringing the position to 242,706 shares worth $5.84M. The position accounts for 0.15% of the portfolio, ranked #120.

Atomi Financial Group first reported a position in PFE in Q1 2023 and has held it in 14 quarters since. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Atomi Financial Group held 242,706 shares of Pfizer worth $5.84M as of Q2 2026.
  • Atomi Financial Group bought 159,955 Pfizer shares in Q2 2026, an estimated $4.18M.
  • Pfizer made up 0.15% of Atomi Financial Group's portfolio in Q2 2026, its #120 holding.
  • Atomi Financial Group first reported a position in Pfizer in Q1 2023 and has held it in 14 quarters since.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.